InflaRx N.V. News
Latest updates and market news for IFRX
3 news
Mar 14 - Mar 20, 2026
Page 1
GlobeNewswire
InflaRx Announces Late-Breaker Oral Presentation on Vilobelimab Phase 3 Results in Pyoderma Gangrenosum at 2026 American Academy of Dermatology Annual Meeting
📈
AI Sentiment
Highly Positive
8/10
Share this news page